SOURCE: Unipathic Medicine

Unipathic Medicine Saves Lives

March 04, 2015 13:37 ET

Unipathic Medicine Reveals Better Treatment for Chronic Lyme Disease

SCOTTSDALE, AZ--(Marketwired - March 04, 2015) - Patients all over the US (and some in other parts of the world) are suffering from Lyme disease because they are not getting the right comprehensive treatment. The people that suffer the most are the ones who have had the Lyme disease infection for an extended period of time or their situation is complicated by other co-infections. We call this medical situation Chronic Lyme disease Complex or CLDC, which is defined as involving one or more factors: Lyme disease; its co-infections; the reactivation of dormant infections, such as viruses, fungal and parasitic infections; and/or an immune compromised state that can be further complicated by heavy metal toxicity, chemical toxicities, essential nutritional deficiencies and structural impairments as part of the etiology of the chronic disease. In response to this "complex" Unipathic Medicine has constructed a feature piece on http://unipathicmedicine.org to discuss all of the problems encountered when treating Lyme disease with the ultimate goal to reveal to physicians how they should approach treatment, including what treatment options patients need to have access to. The key to approaching Lyme disease is being aware of all of the complexities and being able to address them, using a unique medical blueprint with the best technologies from around the world. Traditional treatment with antibiotics is effective for early stages of Lyme disease, but it only scratches the surface when treating late-stage Lyme disease, or what Unipathic Medicine calls Chronic Lyme disease Complex.

First off, antibiotics are only effective at treating bacteria. With Chronic Lyme disease Complex, however, we encounter a medical situation that is complicated by co-infections that can be viral and parasitic in nature, and this is something that antibiotics cannot treat. Another main component blocking antibiotic effectiveness is biofilm. Raphael Stricker, a leader in Lyme disease research states that, "These adherent polysaccharide-based matrices protect bacteria from the hostile host environment and facilitate persistent infection." Biofilm presence complicates matters by protecting the bacterial Borrelia Lyme disease infection. The good news is that Unipathic Medicine has anti-biofilm technology and combines it with advanced immunotherapy, aggressive natural antiviral treatments, antifungal treatments, IV antibiotics and biodetoxification. When this is provided to a properly trained integrative physician and administered as part of a customized treatment plan, these therapies can help bring patients back to optimal health.

In Lyme disease, the nervous system and neurochemistry is disrupted because the infection directly disrupts the neuroendocrine and immune systems. Borrelia (Lyme disease) and its co-infections produce dangerous neurotoxins that block those receptor sites on the nerve cells, thereby prohibiting the correct function on the neurotransmitters. A simple solution is amino acids; which can balance these neurotransmitters by feeding the pathways, but this isn't enough. Physicians must balance neurotransmitters while treating all of the infections properly to include viral, fungal and parasitic factors, and remove chemical/environmental toxins and heavy metals in a customized complete treatment plan. After that happens, patients see long term benefits. At the end of the treatment plan, a patient should be given targeted IV antibiotics to finish off their Lyme disease infection.

To learn more, go to our website at http://unipathicmedicine.org/.

Image Available: http://www.marketwire.com/library/MwGo/2015/3/4/11G034887/Images/unipathic_tick-169264729485.jpg

Contact Information